D
Spero Therapeutics, Inc. SPRO
$1.87 $0.010.54% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -1.70M -13.87M -20.89M -17.15M -17.86M
Total Depreciation and Amortization -- -- 0.00 0.00 2.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 992.00K 1.83M 1.77M 2.42M 2.37M
Change in Net Operating Assets -16.99M 8.04M -4.28M 27.49M -3.26M
Cash from Operations -17.69M -4.00M -23.40M 12.76M -18.74M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -- -- -- --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -17.69M -4.00M -23.40M 12.76M -18.74M